Cargando…
Telomerase activity in plasma cell dyscrasias
Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and pla...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363791/ https://www.ncbi.nlm.nih.gov/pubmed/11237381 http://dx.doi.org/10.1054/bjoc.2000.1655 |
_version_ | 1782153792413761536 |
---|---|
author | Xu, D Zheng, C Bergenbrant, S Holm, G Björkholm, M Yi, Q Gruber, A |
author_facet | Xu, D Zheng, C Bergenbrant, S Holm, G Björkholm, M Yi, Q Gruber, A |
author_sort | Xu, D |
collection | PubMed |
description | Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign http://www.bjcancer.com |
format | Text |
id | pubmed-2363791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23637912009-09-10 Telomerase activity in plasma cell dyscrasias Xu, D Zheng, C Bergenbrant, S Holm, G Björkholm, M Yi, Q Gruber, A Br J Cancer Regular Article Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-03 /pmc/articles/PMC2363791/ /pubmed/11237381 http://dx.doi.org/10.1054/bjoc.2000.1655 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Xu, D Zheng, C Bergenbrant, S Holm, G Björkholm, M Yi, Q Gruber, A Telomerase activity in plasma cell dyscrasias |
title | Telomerase activity in plasma cell dyscrasias |
title_full | Telomerase activity in plasma cell dyscrasias |
title_fullStr | Telomerase activity in plasma cell dyscrasias |
title_full_unstemmed | Telomerase activity in plasma cell dyscrasias |
title_short | Telomerase activity in plasma cell dyscrasias |
title_sort | telomerase activity in plasma cell dyscrasias |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363791/ https://www.ncbi.nlm.nih.gov/pubmed/11237381 http://dx.doi.org/10.1054/bjoc.2000.1655 |
work_keys_str_mv | AT xud telomeraseactivityinplasmacelldyscrasias AT zhengc telomeraseactivityinplasmacelldyscrasias AT bergenbrants telomeraseactivityinplasmacelldyscrasias AT holmg telomeraseactivityinplasmacelldyscrasias AT bjorkholmm telomeraseactivityinplasmacelldyscrasias AT yiq telomeraseactivityinplasmacelldyscrasias AT grubera telomeraseactivityinplasmacelldyscrasias |